Science & Technology
MUSICO: An in silico platform for evaluating the effects of disease and drug effectiveness in HCM and DCM cardiomyopathies
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43HL180216-01
Award Ceiling
$298K
Award Floor
$298K
Close Date
Jul 14, 2026
121 days leftTotal Funding
$298K
Expected Awards
1
Posted Date
Jul 15, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R43HL180216-01
Description
SBIR Phase Phase I award: "MUSICO: An in silico platform for evaluating the effects of disease and drug effectiveness in HCM and DCM cardiomyopathies" awarded to FILAMENTECH, INC. in NEWARK, Delaware. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $297,720. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.